Literature DB >> 8831478

Quantitative clinical measure of spasticity in children with cerebral palsy.

J R Engsberg1, K S Olree, S A Ross, T S Park.   

Abstract

OBJECTIVE: This investigation developed an objective measure to quantify the degree of spasticity.
DESIGN: Specifications included a single variable that integrated key elements characterizing spasticity: velocity, range of motion, and resistance to passive motion. A dynamometer at a children's hospital quantified the passive resistance of the hamstrings to knee extension for a range of motion at 4 different speeds for the prospective descriptive investigation. PATIENTS: A convenience sample of six children with able bodies and 17 children with spastic diplegic cerebral palsy volunteered. DATA PROCESSING: Torque-angle data were processed to calculate the work done by the machine on the children for each speed and then determine the slope of the work-velocity curves. This slope was considered to be the measure of spasticity and it was hypothesized that children with cerebral palsy would have a greater slope than children with able bodies. An independent test determined whether a significant difference existed between groups (p < .05).
RESULTS: Torque-angle data for children with able bodies indicated little change in passive resistance as a function of speed. Similar data for children with cerebral palsy indicated larger resistive torques with increasing speed. Slope from the work-velocity data was close to zero for children with able bodies [.003 J/(degrees/sec)], while the corresponding slope for children with cerebral palsy was approximately 10 times greater [.031 J/(degrees/sec)] and significantly different (p < .05).
CONCLUSION: The slope of the work-velocity data integrates three major components characterizing spasticity, it is a single number that can easily be evaluated and interpreted in a clinical setting, and it utilizes a machine that is available at many centers.

Entities:  

Mesh:

Year:  1996        PMID: 8831478     DOI: 10.1016/s0003-9993(96)90301-9

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

1.  Effect of selective dorsal rhizotomy in the treatment of children with cerebral palsy.

Authors:  Jack R Engsberg; Sandy A Ross; David R Collins; Tae Sung Park
Journal:  J Neurosurg       Date:  2006-07       Impact factor: 5.115

2.  Dynamometer-based measure of spasticity confirms limited association between plantarflexor spasticity and walking function in persons with multiple sclerosis.

Authors:  Theodore R Kremer; Linda R Van Dillen; Joanne M Wagner
Journal:  J Rehabil Res Dev       Date:  2014

3.  Biomechanical assessment with electromyography of post-stroke ankle plantar flexor spasticity.

Authors:  Deog Young Kim; Chang-il Park; Joong Son Chon; Suk Hoon Ohn; Tae Hoon Park; In Keol Bang
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

4.  Predicting functional change from preintervention measures in selective dorsal rhizotomy.

Authors:  Jack R Engsberg; Sandy A Ross; David R Collins; Tae Sung Park
Journal:  J Neurosurg       Date:  2007-04       Impact factor: 5.115

5.  Spastic velocity threshold constrains functional performance in cerebral palsy.

Authors:  Ann E Tuzson; Kevin P Granata; Mark F Abel
Journal:  Arch Phys Med Rehabil       Date:  2003-09       Impact factor: 3.966

6.  Age and electromyographic frequency alterations during walking in children with cerebral palsy.

Authors:  Richard T Lauer; Samuel R Pierce; Carole A Tucker; Mary F Barbe; Laura A Prosser
Journal:  Gait Posture       Date:  2009-10-23       Impact factor: 2.840

7.  Reliability of Ashworth and Modified Ashworth scales in children with spastic cerebral palsy.

Authors:  Akmer Mutlu; Ayse Livanelioglu; Mintaze Kerem Gunel
Journal:  BMC Musculoskelet Disord       Date:  2008-04-10       Impact factor: 2.362

8.  Effects of oral motor therapy in children with cerebral palsy.

Authors:  Seray Nural Sığan; Tuğçe Aksu Uzunhan; Nur Aydınlı; Emine Eraslan; Barış Ekici; Mine Calışkan
Journal:  Ann Indian Acad Neurol       Date:  2013-07       Impact factor: 1.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.